📌 Key Takeaways
- Topic: Silica Stocks: Publicly Listed Silica and Quartz Companies to Know
- Keywords: respirable crystalline silica OSHA
- Published: 2026-11-20 02:49:01
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Mica Powder vs Silica: Properties and Applications Compared
- Silica Market Trends 2026: Demand Drivers, Technologies and Regional Outlook
- This review provides an overview of the development of MSNs in the biomedical field, highlighting some key research advances, briefly summarizing the types of MSNs developed by different research groups (M41S-series, SBA-series, FDU-series, KIT-series, etc.). Moreover, in view of the high versatility of MSNs-based nanocomposites for diagnostic and therapeutic applications, the current MSNs-based architectures and the types of nanocomposites by active elements are summarized. Subsequently, the purpose of surface functionalization of MSNs is examined. Further, we comprehensively review the biomedical applications of MSNs, among them biosensing, bioimaging, targeted disease therapy, and tissue engineering, etc. In particular, targeted therapeutic modalities based on various strategies are meticulously discussed. Finally, the current status of MSNs in clinical trials is presented. It is believed that this review will deliver a thorough understanding of MSNs involved in the development history, design, functionalization, and biomedical applications. In spite of numerous breakthroughs, the current challenges in MSNs research include three chief facets: systematic toxicity study, construction of straightforward but efficient MSNs-based nanoplatforms, and in-depth insight into the in vivo action mechanism.
- Fumed Silica Price: 2026 Price Ranges, Grade Differences and Cost Drivers
- Novoray: Company Overview, Spherical Silica Products and Applications
- Bulk Silica Powder: Packaging Options, MOQ and Bulk Pricing Guide
- Huo, Q. et al. Generalized synthesis of periodic surfactant/inorganic composite materials. Nature 368, 317-321 (1994). Article CAS Google Scholar
Silica TDS: What a Technical Data Sheet Includes and How to Compare Grades
What is silica (SiO₂)?
silica gel Lehman, S. E. et al. Silica nanoparticle-generated ROS as a predictor of cellular toxicity: mechanistic insights and safety by design. Environ. Sci. Nano 3, 56-66 (2016). Post CAS PubMed Google Scholar
What is the difference between fumed silica and precipitated silica?
copper clad laminate filler
What drives silica raw material prices?
water glass Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, owing to their readily tunable structure and composition, various surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide range of MSNs-based nanoplatforms through careful design and controlled preparation approaches, demonstrating their adaptability to diverse biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are steadily moving from basic research to clinical trials. In this review, we supply a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their expansion history. We then discuss the types of MSNs-based nanostructured architectures, along with the classification of MSNs-based nanocomposites according to the elements existed in diverse inorganic functional factors. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we examine the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Lastly, we take a perspective on the future direction and remaining difficulties of MSNs in the biomedical field.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.